Tuesday, March 4, 2025
Home > Longevity

Pfizer-Backed VitaDAO Votes on Creating For-Profit Company to Fund Longevity Research

The company, to be called VitaTech, would leverage public funding to license longevity technologies developed in U.S. universities and support their continued development. The funds would come from research foundations and government grants such as the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR). Source

Read More

VitaDAO Closes $4.1M Funding Round With Pfizer Ventures for Longevity Research

VitaDAO was started in 2021 by Tyler Golato of decentralized biotech protocol Molecule to fund longevity research. According to the organization, it boasts a community of over 9,000 "enthusiasts, researchers and contributors," and deployed over $3.5 million to projects researching diseases of aging, cellular biology and repairing age-related damage to

Read More

Keith Comito on the benefits of blockchain tech and decentralization in longevity research

Lifespan.io President and co-founder Keith Comito was into longevity before longevity was cool.“We started our nonprofit back in 2014,” Comito said. “Back then, few credible researchers would be caught dead saying they were working on aging. It was still kind of a scientific backwater. So, we wanted to emulate what

Read More

The future of longevity lies with digital currency visionaries

The promise of a longer and healthier life has dominated both cultural and medical discourse for centuries. From the first accounts of Nicolas Flamel’s philosopher’s stone granting immortality to the latest superfood that promised to reverse aging, we are captivated by the idea of a longer and more vibrant life.

Read More